UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biomarkers for Alzheimer's disease: current status and prospects for the future

Journal of internal medicine, 2018-12, Vol.284 (6), p.643-663

2018

Volltextzugriff (PDF)

CSF evidence of pericyte damage in Alzheimer's disease is associated with markers of blood-brain barrier dysfunction and disease pathology

Alzheimer's research & therapy, 2019-09, Vol.11 (1), p.81-81, Article 81

2019

Volltextzugriff (PDF)

Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology‐based cohort

European journal of neurology, 2017-11, Vol.24 (11), p.1326-e77

2017

Volltextzugriff (PDF)

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

Neurology, 2009-12, Vol.73 (24), p.2061-2070

2009

Volltextzugriff (PDF)

2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (7), p.2121-2139

2021

Volltextzugriff (PDF)

A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes

Journal of neurology, neurosurgery and psychiatry, 2015-11, Vol.86 (11), p.1240-1247

2015

Volltextzugriff (PDF)

The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (7), p.2140-2156

2021

Volltextzugriff (PDF)

CSF biomarkers for mild cognitive impairment

Journal of internal medicine, 2004-09, Vol.256 (3), p.224-234

Blennow, K.

2004

Volltextzugriff (PDF)

Predicting MCI outcome with clinically available MRI and CSF biomarkers

Neurology, 2011-10, Vol.77 (17), p.1619-1628

2011

Volltextzugriff (PDF)

Harmonized diagnostic criteria for Alzheimer's disease: recommendations

Journal of internal medicine, 2014-03, Vol.275 (3), p.204-213

2014

Volltextzugriff (PDF)

An interim exploratory proteomics biomarker analysis of a phase 2 clinical trial to assess the impact of CT1812 in Alzheimer's disease

Neurobiology of disease, 2024-09, Vol.199, p.106575, Article 106575

2024

Volltextzugriff (PDF)

Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing–remitting multiple sclerosis

European journal of neurology, 2017-05, Vol.24 (5), p.703-712

2017

Volltextzugriff (PDF)

Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

Journal of internal medicine, 2004-09, Vol.256 (3), p.240-246

2004

Volltextzugriff (PDF)

CSF biomarkers predict a more malignant outcome in Alzheimer disease

Neurology, 2010-05, Vol.74 (19), p.1531-1537

2010

Volltextzugriff (PDF)

Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases

Alzheimer's research & therapy, 2020-02, Vol.12 (1), p.19-19, Article 19

2020

Volltextzugriff (PDF)

Identifying clinically useful biomarkers in neurodegenerative diseases–Moving from CSF to blood

Clinica chimica acta, 2024-05, Vol.558, p.118557, Article 118557

Blennow, K.

2024

Volltextzugriff (PDF)

Effective communications on invasive alien species: Identifying communication needs of Swedish domestic garden owners

Journal of environmental management, 2023-08, Vol.340, p.117995-117995, Article 117995

2023

Volltextzugriff (PDF)

Glycan biomarkers for Alzheimer disease correlate with T‐tau and P‐tau in cerebrospinal fluid in subjective cognitive impairment

The FEBS journal, 2020-08, Vol.287 (15), p.3221-3234

2020

Volltextzugriff (PDF)

Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease

Journal of internal medicine, 2021-09, Vol.290 (3), p.583-601

2021

Volltextzugriff (PDF)

Intrathecal inflammation precedes development of Alzheimer’s disease

Journal of neurology, neurosurgery and psychiatry, 2003-09, Vol.74 (9), p.1200-1205

2003

Volltextzugriff (PDF)

The role of beliefs, expectations and values in decision-making favoring climate change adaptation-implications for communications with European forest professionals

Environmental research letters, 2020-11, Vol.15 (11), p.114061

2020

Volltextzugriff (PDF)

Head trauma in sports – clinical characteristics, epidemiology and biomarkers

Journal of internal medicine, 2019-06, Vol.285 (6), p.624-634

2019

Volltextzugriff (PDF)

Abnormality in glutamine-glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study

Translational psychiatry, 2016-03, Vol.6 (3), p.e744-e744

2016

Volltextzugriff (PDF)

Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center study

Multiple sclerosis, 2024-05, Vol.30 (6), p.664-673

2024

Volltextzugriff (PDF)

Atrial fibrillation increases the risk of dementia amongst older adults even in the absence of stroke

Journal of internal medicine, 2019-07, Vol.286 (1), p.101-110

2019

Volltextzugriff (PDF)

1 – 25 von 1.670

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.624)
Mit Volltextzugriff
(1.357)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Biomarkers for Alzheimer's disease: current status and prospects for the future

CSF evidence of pericyte damage in Alzheimer's disease is associated with markers of blood-brain barrier dysfunction and disease pathology

Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology‐based cohort

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes

The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers

CSF biomarkers for mild cognitive impairment

Predicting MCI outcome with clinically available MRI and CSF biomarkers

Harmonized diagnostic criteria for Alzheimer's disease: recommendations

An interim exploratory proteomics biomarker analysis of a phase 2 clinical trial to assess the impact of CT1812 in Alzheimer's disease

Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing–remitting multiple sclerosis

Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

CSF biomarkers predict a more malignant outcome in Alzheimer disease

Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases

Identifying clinically useful biomarkers in neurodegenerative diseases–Moving from CSF to blood

Effective communications on invasive alien species: Identifying communication needs of Swedish domestic garden owners

Glycan biomarkers for Alzheimer disease correlate with T‐tau and P‐tau in cerebrospinal fluid in subjective cognitive impairment

Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease

Intrathecal inflammation precedes development of Alzheimer’s disease

The role of beliefs, expectations and values in decision-making favoring climate change adaptation-implications for communications with European forest professionals

Head trauma in sports – clinical characteristics, epidemiology and biomarkers

Abnormality in glutamine-glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study

Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center study

Atrial fibrillation increases the risk of dementia amongst older adults even in the absence of stroke

Suchergebnisse filtern